Volume 21, Issue 1 & 2

Decoupling From Animal Testing and Making Medical Research Human-Specific: A Conversation With Aysha Akhtar

We need to get back to studying human biology, not the biology of a mouse, cat, dog, or monkey. Replacing animal experimentation is a win-win for humans and animals. We need to stop trying to artificially create animal “models” of human diseases that are never the same diseases as what occurs naturally in humans. We need to embrace newer technologies that allow us to study human biology and human diseases. Think how much further ahead we would be if instead, we used those billions and the bright scientific minds to focus on human biology?

Public HealthHHPRJanuary 13, 2022regulation, technology, testing, biomedical research, ethicsComment

A Simple Solution to the Problem of “Product Hopping”

In this piece, Professor Carrier explains why legislation addressing product hopping is the best option to address this anticompetitive behavior. He focuses on the Affordable Prescriptions for Patients Act of 2021, bipartisan legislation that addresses the harms from product hopping while appropriately deferring to any reasonable justifications the drug company could offer. He explains how the legislation is conservative in several ways and addresses the industry’s argument that product-hopping legislation harms innovation. And he concludes that legislation can play a crucial role in ensuring that consumers have access to affordable generic medicines.

PharmaceuticalsHHPRDecember 23, 2021Pharmaceuticals, drugs, congress, legislation, law, health reformComment

A Conversation with Health Economist Dr. Austin Frakt on Drug Pricing, The Pandemic, and Data Access

HHPR Senior Editor James Jolin interviewed Austin Frakt, Ph.D., a Health Economist and Director of the Partnered Evidence-based Policy Resource Center at the Boston VA Healthcare System. They discussed drug pricing, the pandemic and data access.

HHPRDecember 5, 2021Comment

Vaccines, Regulation, and Patents: A Conversation with Harvard Medical School Professor Dr. Jonathan J. Darrow

HHPR Senior Editor James Jolin interviewed Jonathan Darrow, S.J.D., LL.M., J.D., M.B.A, an Assistant Professor of Medicine at Harvard Medical School and a Faculty Member of the Center for Bioethics. They discussed vaccine development, pharmaceutical regulation and patents.

Public HealthHHPRDecember 2, 2021interview, vaccine, regulation, patents, PharmaceuticalsComment

Precision Psychiatry in the 21st Century: An Interview with Dr. Ronald Kessler

HHPR Senior Editor Sarosh Nagar interviewed Ronald Kessler, Ph.D., to hear about the future of precision psychiatry and its use in preventing mental illness.

HHPROctober 22, 2021Comment

The Pre-Existing Condition of Food Insecurity: How Structural Racism Causes Food Inequality and What the Biden Administration Can Do to Resolve It

Food is an essential aspect of human life. Without it, the very existence of humanity would perish. Yet, it is not a right all are afforded.

food insecurityHHPRSeptember 26, 2021food insecurity, health equity, public health, bidenComment